IVBT — Innovation1 Biotech Cashflow Statement
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
- $0.00m
- $0.50m
Annual cashflow statement for Innovation1 Biotech, fiscal year end - August 31st, USD millions except per share, conversion factor applied.
2019 August 31st | 2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | — | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | |
| Standards: | USG | USG | — | USG | USG |
| Status: | Final | Final | fx Preliminary | Final | Final |
| Net Income/Starting Line | -0.17 | -2.58 | — | -40.9 | -5.99 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -0.451 | 1.46 | — | 35.8 | 4.09 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.157 | 0.702 | — | -0.433 | 1.27 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.776 | -0.41 | — | -3.13 | -0.62 |
| Capital Expenditures | -0.007 | 0 | — | -0.853 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -0.3 | — | — | — |
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.007 | -0.3 | — | -0.853 | 0 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.027 | 0.709 | — | 4 | 0.514 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.755 | -0.001 | — | 0.019 | -0.107 |